SWOT Analysis for iSpecimen Inc

Companies with 10% increase in share price over three months, with rising net profit growth
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
Volume Shockers
Biggest Price Gainers from Open

Negative Breakdown Third Support (LTP < S3)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Biggest Price Losers from Open
High volume, top losers
Top Losers
Negative Breakdown First Support (LTP < S1)
Negative Breakdown Second Support (LTP < S2)
Negative Breakdown third support (LTP < S3)
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Declining Revenue every quarter for the past 3 quarters
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter